Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PerioTabs is a NitrAdine-based brushing solution developed for the treatment of gingival inflammation, including gingivitis and periodontitis. The formulation utilizes a slow-release 0.02% hypochlorite-based disinfectant system that effectively disrupts and removes dental biofilms. It is administered as a 10-day intensive brushing regimen where a tablet is dissolved in water to create a solution, providing a non-antibiotic alternative to traditional oral antiseptics like chlorhexidine. By targeting the bacterial plaque responsible for periodontal disease, PerioTabs reduces gingival bleeding and plaque accumulation with minimal side effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on PerioTabs.